全文获取类型
收费全文 | 5996篇 |
免费 | 1111篇 |
国内免费 | 182篇 |
出版年
2024年 | 40篇 |
2023年 | 204篇 |
2022年 | 256篇 |
2021年 | 409篇 |
2020年 | 417篇 |
2019年 | 497篇 |
2018年 | 334篇 |
2017年 | 294篇 |
2016年 | 276篇 |
2015年 | 304篇 |
2014年 | 452篇 |
2013年 | 529篇 |
2012年 | 318篇 |
2011年 | 353篇 |
2010年 | 237篇 |
2009年 | 239篇 |
2008年 | 229篇 |
2007年 | 221篇 |
2006年 | 206篇 |
2005年 | 165篇 |
2004年 | 162篇 |
2003年 | 129篇 |
2002年 | 111篇 |
2001年 | 67篇 |
2000年 | 67篇 |
1999年 | 83篇 |
1998年 | 77篇 |
1997年 | 78篇 |
1996年 | 61篇 |
1995年 | 55篇 |
1994年 | 51篇 |
1993年 | 35篇 |
1992年 | 53篇 |
1991年 | 41篇 |
1990年 | 38篇 |
1989年 | 48篇 |
1988年 | 23篇 |
1987年 | 27篇 |
1986年 | 8篇 |
1985年 | 24篇 |
1984年 | 14篇 |
1983年 | 11篇 |
1982年 | 5篇 |
1981年 | 14篇 |
1980年 | 7篇 |
1979年 | 6篇 |
1978年 | 4篇 |
1977年 | 2篇 |
1975年 | 3篇 |
1974年 | 2篇 |
排序方式: 共有7289条查询结果,搜索用时 109 毫秒
61.
Felix P. Exkenstien 《Developmental neurobiology》1994,25(11):1467-1480
Fibroblast growth factors (FGFs) exhibit widespread mitogenic and neurotrophic activities. Nine members of the family are currently known, and FGF-1 and FGF-2 are present in relatively high levels in CNS. FGF-1 is expressed by a subset of neuronal populations, while FGF-2 is expressed by astrocytes. FGF-1 and FGF-2 lack signal peptides and appear to be present mainly in inracellular compartmens. This suggests that the factors may act as initiators of a repair response after injury. Support for this notion comes from observations that FGF-1 and FGF-2 levels are low during critical phases of development, but high in the adult CNS. A family of transmembrane tyrosine kinase receptors (FGFRs) mediates the effects of FGFs. Four different genes coding for FGF receptors are currently known, three of which are expressed in cell type-specific patterns in the CNS The main receptor variants present in this tissue, however, can by themselves not distinguish between FGF-1 and FGF-2. Additional selectivity may be established by interaction of the FGFs and their receptors with select heparan proteoglycans (HSPGs). Therefore, the precise physiological role of FGFs is determined by the combination of cell type-specific patterns of expression of FGFs, FGFRs and HSPGs together with the mechanisms that regulate the extracellular availability of FGFs. 1994 John Wiley & Sons, Inc. 相似文献
62.
内毒素致大鼠肺损伤时肺组织β受体的变化与膜磷脂代谢的关系 总被引:1,自引:0,他引:1
采用放射性配基结合分析法,现察内毒大致大鼠急性肺损伤时肺β-肾上腺素能受体(β-AR)的变化。分别用荧光偏振法和高效液相色谱测定肺组织细胞膜脂流动性和磷脂含量。结果显示:(1)静脉注射内毒素后4h,大鼠肺β-AR的最大结合容量明显降低,较对照组减少47%;(2)内毒素组肺膜脂流动性和磷脂含量均明显降低,同时伴有肺组织磷脂酶A2(PLA2)活性升高。提示:(1)β-AR下调导致其介导的功能减弱,在内毒素诱导的大鼠急性肺损伤发病机理中起一定作用;(2)PLA2激活是膜磷脂减少的重要原因,后者可导致膜脂流动性降低,结果引起β-AR的侧向扩散和旋转运劝减弱,从而减少β-AR与配基结合的机率,出现β-AK下调。 相似文献
63.
人肝刺激因子对大鼠实验性慢性肝损伤的保护作用 总被引:3,自引:0,他引:3
从健康孕妇水囊引产4─6个月龄的胎儿取肝,采用LaBrecque方法提取人肝刺激因子(hHSS)。经3H-胸腺嘧啶核苷参入肝DNA法测定其生物活性。表明此hHSS可刺激肝细胞DNA合成。采用皮下注射CCl4和饮用10%乙醇来制备慢性肝损伤动物模型,观察了hHSS的保护肝脏作用。结果表明:hHSS可使CCl4-乙醇所致慢性肝损伤大鼠的死亡率、血清谷丙转氨酶水平、肝组织中羟脯氨酸含量的升高以及肝组织中丙二醛的含量降低。肝组织切片表明:hHSS能减轻肝组织的损伤程度,促进肝细胞再生,并能明显防止肝纤维化的形成和发展。可见,hHSS对CCl4-乙醇所致的慢性肝损伤大鼠有明显的保护作用,其机制可能与促进肝细胞再生及抑制肝细胞膜的脂质过氧化有关。 相似文献
64.
以D-氨基半乳糖(D-Galactosamine,D-GalN)造成急性肝损伤(急性肝炎、急性肝坏死)大鼠模型后、对照观察了急性肝损伤大鼠血浆氨基酸的变化,建立了大鼠急性肝损伤时血浆氨基酸的变化模式并对其发生机理进行了探讨。大鼠血浆氨基酸的测定采用聚酰薄层荧光分析技术,其测定结果是:急性肝炎组,酪氨酸(Tyr)、天冬氨酸(Asp)、谷氨酰胺(Gln)和鸟氨酸(Orn)升高,精氨酸(Arg)下降,其余氨基酸无显著变化。急性肝坏死组,除Arg显著下降外,其余所有氨基酸都显著升高,而两组支链氨基酸(BCAA)/芳香族氨基酸(AAA)克分子比值均显著下降。 相似文献
65.
通过对80例急性脑出血死亡组分析,发现死于脑疝的占62.5%,脑疝与一种或二种以上合并症同存者占77.5%,显著高于存活组(P<0.01).它们互为因果,加速死亡。因此,应重视早期或超早期采用简易定向锥颅脑内血肿碎吸术吸除血肿,同时注意维持生命体征稳定,加强脱水降颅压,预防、控制合并症等综合治疗。且要全面分析,相互兼顾,正确处置。这是帮助机体渡过调控障碍难关,挽救生命的有效治疗措施。 相似文献
66.
J. Iba?ez R. Rama M. Riera M. T. Prats L. Palacios 《European journal of applied physiology and occupational physiology》1993,67(1):7-13
The effect of severe acute hypoxia (fractional concentration of inspired oxygen equalled 0.104) was studied in nine male subjects performing an incremental exercise test. For power outputs over 125 W, all the subjects in a state of hypoxia showed a decrease in oxygen consumption (
O2) relative to exercise intensity compared with normoxia (P < 0.05). This would suggest an increased anaerobic metabolism as an energy source during hypoxic exercise. During submaximal exercise, for a given
O2, higher blood lactate concentrations were found in hypoxia than in normoxia (P < 0.05). In consequence, the onset of blood lactate accumulation (OBLA) was shifted to a lower
O2 (
O2 1.77 l·min–1 in hypoxia vs 3.10 l·min–1 in normoxia). Lactate concentration increases relative to minute ventilation (
E) responses were significantly higher during hypoxia than in normoxia (P < 0.05). At OBLA,
E during hypoxia was 25% lower than in the normoxic test. This study would suggest that in hypoxia subjects are able to use an increased anaerobic metabolism to maintain exercise performance. 相似文献
67.
Shikha Bakshi Maninder Kaur Arpana Verma Sadhna Sharma 《Journal of biochemical and molecular toxicology》2023,37(8):e23386
Drug-induced liver injury (DILI) is an adverse outcome of the currently used tuberculosis treatment regimen, which results in patient noncompliance, poor treatment outcomes, and the emergence of drug-resistant tuberculosis. DILI is primarily caused by the toxicity of the drugs and their metabolites, which affect liver cells, biliary epithelial cells, and liver vasculature. However, the precise mechanism behind the cellular damage attributable to first-line antitubercular drugs (ATDs), as well as the effect of toxicity on the cell survival strategies, is yet to be elucidated. In the current study, HepG2 cells upon treatment with a high concentration of ATDs showed increased perforation within the cell, cuboidal shape, and membrane blebbing as compared with control/untreated cells. It was observed that ATD-induced toxicity in HepG2 cells leads to altered mitochondrial membrane permeability, which was depicted by the decreased fluorescence intensity of the MitoRed tracker dye at higher drug concentrations. In addition, high doses of ATDs caused cell damage through an increase in reactive oxygen species production in HepG2 cells and a simultaneous reduction in glutathione levels. Further, high dose of isoniazid (50–200 mM), pyrazinamide (50–200 mM), and rifampicin (20–100 µM) causes cell apoptosis and affects cell survival during toxic conditions by decreasing the expression of potent autophagy markers Atg5, Atg7, and LC3B. Thus, ATD-mediated toxicity contributes to the reduced ability of hepatocytes to tolerate cellular damage caused by altered mitochondrial membrane permeability, increased apoptosis, and decreased autophagy. These findings further emphasize the need to develop adjuvant therapies that can mitigate ATD-induced toxicity for the effective treatment of tuberculosis. 相似文献
68.
Fluorescence Microscopy of Fresh Tissue as a Rapid Technique for Assessing Early Injury to Mesophyll
A technique was developed for sectioning fresh red spruce foliage (Picea rubens Sarg.) for use in fluorescence microscopy. This allowed rapid examination of mesophyll in 3-5 mm needle sections. Healthy, ozone treated and cold stressed needles were examined to assess the utility of this technique for early detection of damage. Healthy mesophyll cells fluoresced bright red, while injured cells fluoresced yellow-green in ozone treated needles, and yellow-orange in frozen needles. Shifts in fluorescence wavelengths may be useful for early detection of injury to mesophyll before it is evident by standard light or electron microscopy. 相似文献
69.
70.
Anding Wu Mao Ye Tengfei Ma Zhigang She Ruyan Li Hongjie Shi Ling Yang Maolin Yi Huoping Li 《Journal of cellular physiology》2023,238(2):393-406
Nonalcoholic fatty liver disease (NAFLD) is a strong stimulant of cardiovascular diseases, affecting one-quarter of the world's population. TBC1 domain family member 25 (TBC1D25) regulates the development of myocardial hypertrophy and cerebral ischemia–reperfusion injury; however, its effect on NAFLD/nonalcoholic steatohepatitis (NASH) has not been reported. In this study, we demonstrated that TBC1D25 expression is upregulated in NASH. TBC1D25 deficiency aggravated hepatic steatosis, inflammation, and fibrosis in NASH. In vitro tests revealed that TBC1D25 overexpression restrained NASH responses. Subsequent mechanistic validation experiments demonstrated that TBC1D25 interfered with NASH progression by inhibiting abnormal lipid accumulation and inflammation. TBC1D25 deficiency significantly promoted NASH occurrence and development. Therefore, TBC1D25 may potentially be used as a clinical therapeutic target for NASH treatment. 相似文献